| Christopher McCarthy |
Christopher McCarthy is currently the Chief Financial Officer at Interpace Biosciences, Inc. He previously worked as a Senior Financial Systems Analyst at Simon & Schuster, Inc. |
| Thomas W. Burnell |
Thomas W. Burnell is the founder of Milestone Business Management. He currently holds multiple positions including Chairman, President & Chief Executive Officer at Interpace Biosciences, Inc., Chief Executive Officer at Interpace Pharma Solutions, Inc., Chairman at Pioneer Heart Institute, and Director at miraDry, Inc. In the past, he served as President & Chief Executive Officer at Boston Heart Diagnostics Corp., President & Chief Executive Officer at Nebraska Heart Hospital, Vice Chairman, President & Chief Executive Officer at Eurofins Scientific, Inc., President & Chief Executive Officer at The Nebraska Heart Institute PC, President, Chief Executive Officer & Director at Eurofins Viracor, Inc., President & Chief Executive Officer at Elite One Source Nutritional Services, Inc., President & Chief Executive Officer at Mitesco, Inc., President & Chief Executive Officer at Genomicfx, Inc., Executive Chairman at ATS Labs, Inc., Executive Chairman at Accuratus Lab Services, Inc., Director at ViraCor Laboratories LLC, and Partner at Ampersand Management LLC. He obtained undergraduate and graduate degrees from the University of Nebraska and a doctorate degree from the University of Kentucky. |
| Sydney D. Finkelstein |
Sydney D. Finkelstein is currently the Chief Scientific Officer at Interpace Biosciences, Inc. and the President at Redpath Partners, Inc. He is also an Adjunct Professor at Temple University. In the past, he has worked as a Faculty Member at Dartmouth College, Duke University, Northwestern University, and The University of New South Wales. He has also been a Professor at the University of Pittsburgh and Hahnemann University. Additionally, he has been a Faculty Member at Aalto University and London Business School. Dr. Finkelstein holds a doctorate degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from Concordia University, and a graduate degree from the London School of Economics & Political Science. |
| Nicole Massoll |
Nicole Massoll is currently the Chief Medical Officer at Interpace Biosciences, Inc. and also holds the position of Laboratory & Medical Dir.-Rosetta Genomics, East at Rosetta Genomics Ltd. She obtained a doctorate degree from The University of Arkansas. |
| Stephen J. Sullivan |
Stephen J. Sullivan is the founder of Cro Advisors LLC, which was founded in 2010. He is currently an Independent Director at Interpace Biosciences, Inc. since 2004, a Director at Transnetyx, Inc. since 2018, and an Executive Advisor at Thompson Street Capital Managers LLC. Mr. Sullivan has held various former positions including Chairman & Chief Executive Officer at Xenometrix, Inc. from 1996 to 1999, President, Chief Executive Officer & Director at Harlan Laboratories, Inc. from 2006 to 2010, and Chairman at Bioreclamation-IVT Holdings LLC from 2013 to 2016. He also served as Chairman at H2O Clinical LLC, Non-Executive Chairman at BioIVT LLC from 2013 to 2016, Chairman at Microbiology Research Associates, Inc. from 2015 to 2020, and Chairman at Firma Clinical Research LLC from 2016 to 2018. Mr. Sullivan has an MBA from Rutgers State University of New Jersey and an undergraduate degree from the University of Dayton. |
| Jody Campbell |
Jody Campbell is currently the Chief Revenue Officer at Interpace Biosciences, Inc. Prior to this, he worked as a Senior Director at Biodesix, Inc. and as a Manager-District Sales at Hologic, Inc. from 2004 to 2021. He obtained his undergraduate degree from Washington & Jefferson College. |
| Fortunato Ron Rocca |
Fortunato Ron Rocca is currently an Independent Director at Interpace Biosciences, Inc. and a Director at Circular Genomics, Inc. Previously, he served as the President, Chief Executive Officer & Director at Exagen, Inc. from 2011 to 2022. He also worked as a Marketing Director at Elan Pharmaceuticals LLC from 1998 to 2004 and as the Chief Operating Officer at Zoetis Products LLC from 2004 to 2005. Additionally, he held the position of General Manager, Vice President-Sales & Marketing at Prometheus Laboratories, Inc. from 2005 to 2011. Mr. Rocca has a background in undergraduate studies from Towson University. |
| Joseph D. Keegan |
Joseph D. Keegan is currently the Executive Chairman at Carterra, Inc., Chairman at Labcyte, Inc., Chairman at Arrayjet Ltd., Executive Chairman at Optofluidics, Inc., Chairman at Analytical Life Science & Diagnostics Association, Chairman at Fluidic Analytics Ltd., Independent Director at Bio-Techne Corp., Independent Director at Interpace Biosciences, Inc., Independent Director at Biolog, Inc., Director at San Francisco Opera Association, Director at Advanced Cell Diagnostics, Inc., Independent Director at Nuclera Nucleics Ltd., and President at Universal Imaging Corp. Previously, Dr. Keegan served as the Chief Executive Officer at Molecular Devices LLC from 1998 to 2007, Chief Executive Officer at ForteBio, Inc. from 2007 to 2012, Chairman at Seahorse Bioscience, Inc. in 2011, Director at Response Biomedical Corp., Director at Stereotaxis, Inc. from 2013 to 2016, Director at BioImagene, Inc., Director at Courtagen Life Sciences, Inc., Director at Cardea Bio, Inc. from 2016 to 2018, Independent Director at ProteinSimple in 2014, Director at Alpha Innotech Corp. from 2007 to 2009, Director at Essen BioScience, Inc., Director at Upstate USA, Inc., Director at Unchained Labs, and President-Worldwide Tissue Culture at Becton, Dickinson & Co. from 1992 to 1998. He also worked as a Lead Engineer at GE Aerospace and HP, Inc., and as Vice President at Leica Geosystems, Inc.Dr. Keegan holds a doctorate degree from Stanford University and an undergraduate degree from Boston University. |
| Vijay Aggarwal |
Vijay Aggarwal is currently the Chairman of Lesanne Life Sciences LLC and an Independent Director at Interpace Biosciences, Inc. He is also a Director at Moleculera Labs, Inc., Slone Career Strategies, Inc., Genisphere LLC, Discovery Financial Services Pvt Ltd., and AllerGenis LLC. Additionally, he is a Director and Executive Committee Member at Broad Street Angels, a Board Member at New York Angels, Inc., and a Director at AccuGenomics, Inc. In the past, Dr. Aggarwal served as the President & Chief Executive Officer of Aureon Biosciences, Inc. and Chief Executive Officer of VaxiGenix, Inc. He was also a Director at HYCOR Biomedical, Inc., Targeted Diagnostics & Therapeutics, Inc., SmithKline Beecham Clinical Laboratories, Progene Biomedical, Inc., ViraCor Laboratories LLC, MDNA Life Sciences, Inc., Eurofins Viracor, Inc., and Quest Diagnostics, Inc. Additionally, he was the President of AAI Development Services, Inc. and a Managing Partner at The Channel Group. He also worked as a Manager-Toxicology & Special Chemistry at Nelson Laboratories Bozeman LLC. Dr. Aggarwal received his undergraduate degree from Case Western Reserve University and his doctorate from the Medical College of Virginia. |
